Cargando…

Therapie von Long-Covid-Syndromen mit chinesischer Arzneimitteltherapie im Erwachsenen‑, Kindes- und Jugendalter

Chronic sequelae after surviving Covid 19 disease, and also after inapparent or asymptomatic SARS-CoV‑2 infections, represent an increasingly common problem despite the growing number of vaccinated individuals and significantly reduced infection rates in the summer of 2021. For these sufferers of “p...

Descripción completa

Detalles Bibliográficos
Autor principal: Thede, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496622/
http://dx.doi.org/10.1007/s00052-021-00023-3
_version_ 1784579791216705536
author Thede, Christian
author_facet Thede, Christian
author_sort Thede, Christian
collection PubMed
description Chronic sequelae after surviving Covid 19 disease, and also after inapparent or asymptomatic SARS-CoV‑2 infections, represent an increasingly common problem despite the growing number of vaccinated individuals and significantly reduced infection rates in the summer of 2021. For these sufferers of “post-Covid syndrome” Western medicine has been unable to date to offer any significant, established and effective therapy options. In this article, the author presents effective therapeutic concepts offered by Chinese herbal therapy for the treatment of the particularly frequent respiratory and neurological symptoms as well as for “chronic fatigue syndrome” (CFS), with special emphasis on the treatment of special forms of Covid-19 sequelae such as disharmony of lesser yang (shaoyang) with variations of “minor bupleurum decoction” (xiao chaihu tang), also with regard to possible reactivations of chronic EBV infections by corona-virus infections. The article also discusses the significance of Long Covid in children and adolescents and outlines possible therapeutic concepts. The article concludes with two case studies.
format Online
Article
Text
id pubmed-8496622
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Medizin
record_format MEDLINE/PubMed
spelling pubmed-84966222021-10-08 Therapie von Long-Covid-Syndromen mit chinesischer Arzneimitteltherapie im Erwachsenen‑, Kindes- und Jugendalter Thede, Christian Chinese Medicine Zertifizierte Fortbildung Chronic sequelae after surviving Covid 19 disease, and also after inapparent or asymptomatic SARS-CoV‑2 infections, represent an increasingly common problem despite the growing number of vaccinated individuals and significantly reduced infection rates in the summer of 2021. For these sufferers of “post-Covid syndrome” Western medicine has been unable to date to offer any significant, established and effective therapy options. In this article, the author presents effective therapeutic concepts offered by Chinese herbal therapy for the treatment of the particularly frequent respiratory and neurological symptoms as well as for “chronic fatigue syndrome” (CFS), with special emphasis on the treatment of special forms of Covid-19 sequelae such as disharmony of lesser yang (shaoyang) with variations of “minor bupleurum decoction” (xiao chaihu tang), also with regard to possible reactivations of chronic EBV infections by corona-virus infections. The article also discusses the significance of Long Covid in children and adolescents and outlines possible therapeutic concepts. The article concludes with two case studies. Springer Medizin 2021-10-07 2021 /pmc/articles/PMC8496622/ http://dx.doi.org/10.1007/s00052-021-00023-3 Text en © Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Zertifizierte Fortbildung
Thede, Christian
Therapie von Long-Covid-Syndromen mit chinesischer Arzneimitteltherapie im Erwachsenen‑, Kindes- und Jugendalter
title Therapie von Long-Covid-Syndromen mit chinesischer Arzneimitteltherapie im Erwachsenen‑, Kindes- und Jugendalter
title_full Therapie von Long-Covid-Syndromen mit chinesischer Arzneimitteltherapie im Erwachsenen‑, Kindes- und Jugendalter
title_fullStr Therapie von Long-Covid-Syndromen mit chinesischer Arzneimitteltherapie im Erwachsenen‑, Kindes- und Jugendalter
title_full_unstemmed Therapie von Long-Covid-Syndromen mit chinesischer Arzneimitteltherapie im Erwachsenen‑, Kindes- und Jugendalter
title_short Therapie von Long-Covid-Syndromen mit chinesischer Arzneimitteltherapie im Erwachsenen‑, Kindes- und Jugendalter
title_sort therapie von long-covid-syndromen mit chinesischer arzneimitteltherapie im erwachsenen‑, kindes- und jugendalter
topic Zertifizierte Fortbildung
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496622/
http://dx.doi.org/10.1007/s00052-021-00023-3
work_keys_str_mv AT thedechristian therapievonlongcovidsyndromenmitchinesischerarzneimitteltherapieimerwachsenenkindesundjugendalter